Sponsor or institution

Clinical trials and research at Fundación Española de Hematología y Hemoterapía

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Fundación Española de Hematología y Hemoterapía that are recruiting, in Spain. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Registry for patients with Primary Immune Thrombocytopenia in Spain — A Coruña, A Coruña and 35 other locations Recruiting Apr 9, 2025
Prevalence of Acid Sphingomyelinase Deficiency and Gaucher Disease in Patients with Monoclonal Gammopathies — Vitoria-Gasteiz, Alava and 22 other locations Recruiting Aug 15, 2023
Registry for patients with Thrombotic Thrombocytopenic Purpura in Spain and Portugal — Seville, Andalusia and 6 other locations Recruiting Jun 22, 2023
Spanish registry of adults with IgM monoclonal gammopathies including Waldenström macroglobulinemia — Mérida, Badajoz and 50 other locations Recruiting Oct 26, 2021

All recruiting trials (4)

Quick answers

How many clinical trials run by Fundación Española de Hematología y Hemoterapía are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Spain. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.